Formoterol

What is Formoterol?

Formoterol is a long-acting beta-2 adrenergic receptor agonist (LABA) bronchodilator medication used to treat respiratory conditions. It belongs to a class of drugs that help open the airways by relaxing the smooth muscles in the bronchi and bronchioles. Formoterol is primarily prescribed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD).

Uses

Formoterol is approved for several respiratory conditions:

• Asthma maintenance therapy: Used as part of combination therapy with inhaled corticosteroids to prevent asthma symptoms and reduce the frequency of attacks in patients 12 years and older
• COPD management: Helps improve breathing and reduce symptoms in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema
• Exercise-induced bronchospasm prevention: Can be used to prevent breathing difficulties triggered by physical activity when taken before exercise
• Chronic asthma in combination therapy: Often combined with budesonide or other inhaled corticosteroids for comprehensive asthma control
• Maintenance bronchodilation: Provides sustained relief of airway constriction for up to 12 hours per dose

How it works

Formoterol works by binding to beta-2 adrenergic receptors located on the smooth muscle cells lining the airways. When activated, these receptors trigger a cascade that increases levels of cyclic adenosine monophosphate (cAMP), which causes the bronchial muscles to relax and the airways to widen. This bronchodilation effect typically begins within 15 minutes and can last up to 12 hours, making it effective for long-term symptom control.

Side effects

Common side effects include:

Submit Your Paper

• Tremor or shaking, especially in hands
• Headache
• Nervousness or anxiety
• Throat irritation or dry mouth
• Muscle cramps
• Nausea
• Dizziness
• Sleep disturbances

Serious side effects to watch for:

• Chest pain or rapid, irregular heartbeat
• Severe allergic reactions with swelling of face, lips, or throat
• Worsening breathing problems or increased wheezing
• High blood pressure
• Low potassium levels causing weakness or irregular heart rhythm

Warnings and precautions

• Black box warning: LABA medications may increase the risk of asthma-related death when used alone. Formoterol should never be used without an inhaled corticosteroid in asthma patients.
• Cardiovascular conditions: Use with caution in patients with heart disease, high blood pressure, or irregular heart rhythms, as formoterol can increase heart rate and blood pressure.
• Pregnancy and nursing: Classified as FDA pregnancy category C. Should only be used during pregnancy if benefits outweigh potential risks. Caution advised during breastfeeding.
• Diabetes and thyroid disorders: May worsen blood sugar control in diabetics and can exacerbate hyperthyroidism symptoms.
• Seizure disorders: Use cautiously in patients with epilepsy, as beta-agonists may lower seizure threshold in susceptible individuals.

Interactions

• Beta-blockers: May counteract formoterol’s bronchodilating effects and should generally be avoided in respiratory patients
• MAO inhibitors and tricyclic antidepressants: Can potentiate cardiovascular effects, increasing risk of heart rhythm problems
• Diuretics: May increase risk of low potassium levels, especially with thiazide and loop diuretics
• Digoxin: Formoterol may increase digoxin levels, requiring careful monitoring for toxicity
• Other LABA medications: Should not be used together due to increased risk of overdose and cardiovascular effects
• Xanthine derivatives: Combination with theophylline may increase nervous system stimulation and heart rate
• Corticosteroids: While often used together therapeutically, high-dose steroids may increase potassium loss
• QT-prolonging drugs: Increased risk of dangerous heart rhythm changes when combined with medications that affect heart electrical activity

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing varies by formulation and indication. For dry powder inhalers, the usual dose is 12 micrograms twice daily for maintenance therapy. For nebulizer solutions, doses typically range from 12-24 micrograms twice daily. The maximum recommended dose is generally 24 micrograms twice daily. For exercise-induced bronchospasm prevention, a single 12-microgram dose taken 15 minutes before activity is typical. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, response to treatment, and other medications being used.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).